- Business Segment
- Main Products
- Flutiform
- Desalex
- Beova
- Lasvic
- Pentasa
- Kipres
- Mucodyne
- Nasonex
- Uritos
- Montelukast “KM”
- Mometasone “KYORIN”
- Imidafenacin “KYORIN”
Business Segment
(Millions of yen)
| 2018/3 | 2019/3 | 2020/3 | 2021/3 | 2022/3 | |
|---|---|---|---|---|---|
| New ethical drugs, etc. (Japan) | 79,639 | 83,456 | 77,535 | 69,735 | 69,725 |
| New ethical drugs (Overseas) | 3,339 | 830 | 1,490 | 996 | 1,033 |
| Generic drugs | 27,662 | 29,334 | 30,957 | 32,172 | 34,775 |
| Net sales | 110,640 | 113,620 | 109,983 | 102,904 | 105,534 |
“Accounting Standards for Revenue Recognition” (ASBJ Statement No.29, Mar 31, 2020) etc. have been applied from the beginning of March 2022.
Main Products
Flutiform
- Combination drug for asthma treatment
- Flutiform 50 Aerosol - 56 inhalations / 120 inhalations
Flutiform 125 Aerosol - 56 inhalations / 120 inhalations
Desalex
- Antiallergic Agent
- Desalex Tablets 5mg
Beova
- Therapeutic agent for overactive bladder
- Beova Tablets 50mg
Lasvic
- New Quinolone synthetic antibacterial agent
- Lasvic Tablets 75mg
Lasvic Intravenous Drip Infusion Kit 150mg
Pentasa
- Ulcerative Colitis/
Crohn's Disease Remedy - PENTASA Tablets 250 mg
PENTASA Tablets 500 mg
PENTASA Granules 94% - Ulcerative Colitis Remedy
- PENTASA Enema 1 g
PENTASA Suppositories 1 g
Kipres
- Leukotriene receptor antagonist
Anti-Bronchial asthma and allergic rhinitis drug - KIPRES Tablets 5 mg
KIPRES Tablets 10 mg
KIPRES OD Tablets 10 mg - Leukotriene receptor antagonist
Anti-Bronchial asthma drug - KIPRES Fine Granules 4 mg
KIPRES Chewable Tablets 5 mg
Mucodyne
- Mucoregulating drug
- MUCODYNE Tablets 250 mg
MUCODYNE Tablets 500 mg
MUCODYNE Syrup 5%
MUCODYNE DS 50%
Nasonex
- Allergic Rhinitis Therapeutic agent
- NASONEX Nasal 50μg 56sprays
NASONEX Nasal 50μg 112sprays
Uritos
- Therapeutic agent for overactive bladder
- URITOS Tablets 0.1 mg
URITOS OD Tablets 0.1 mg
Montelukast “KM”
- Treatment for Bronchial asthma, allergic rhinitis
- MONTELUKAST Tablets 5mg “KM”
MONTELUKAST Tablets 10mg “KM”
Mometasone “KYORIN”
- Allergic Rhinitis Therapeutic Agent
- MOMETASONE NASAL 50μg “KYORIN”56sprays
MOMETASONE NASAL 50μg “KYORIN”112sprays
Imidafenacin “KYORIN”
- Therapeutic agent for overactive bladder
- IMIDAFENACIN Tablets 0.1mg “KYORIN”
IMIDAFENACIN OD Tablets 0.1mg “KYORIN”
(Billions of yen)
| 2018/3 | 2019/3 | 2020/3 | 2021/3 | 2022/3 | |
|---|---|---|---|---|---|
| Flutiform | 11.9 | 13.1 | 14.6 | 13.3 | 12.6 |
| Desalex | 4.9 | 3.7 | 2.6 | 5.7 | 7.1 |
| Beova | - | 0.7 | 4.3 | 7.3 | 8.6 |
| Lasvic | - | - | 1.1 | 0.9 | 1.8 |
| Pentasa | 15.3 | 13.5 | 13.3 | 12.8 | 14.0 |
| Kipres | 18.8 | 13.9 | 11.8 | 8.3 | 8.4 |
| Mucodyne | 8.7 | 6.8 | 5.8 | 3.3 | 3.5 |
| Nasonex | - | 12.8 | 6.0 | 2.8 | 2.4 |
| Uritos | 7.2 | 6.6 | 5.8 | 2.3 | 1.3 |
| Montelukast “KM” | 11.7 | 11.9 | 11.5 | 10.8 | 12.2 |
| Mometasone “KYORIN” | - | - | 2.8 | 3.8 | 3.6 |
| Imidafenacin “KYORIN” | - | - | - | 0.7 | 0.8 |
